Glenmark Pharmaceuticals share price gained in trade after the company announced the launch of Tevimbra (tislelizumab) in ...

Glenmark Pharmaceuticals on Tuesday said it has launched the lung cancer treatment drug Tevimbra in India, following the ...

Timex Group to sell 15% stake in Indian entity, Hindalco acquires AluChem, CCI approves Bain Capital's stake in Manappuram.

Glenmark Pharmaceuticals launches Tevimbra, a new lung cancer treatment drug, in India. This marks Glenmark's entry into ...

Glenmark Pharmaceuticals has launched the lung cancer drug Tevimbra in India after approval by the Central Drugs Standard Control Organisation. Developed by global oncology leader BeiGene, now BeOne ...

HDFC Mutual Fund has raised its stake in Glenmark Pharmaceuticals to 5.07 percent after acquiring 3.57 lakh shares, despite ...

Glenmark Pharma launches Tevimbra in India to treat lung and esophageal cancer: Our Bureau, Mumbai Tuesday, June 24, 2025, 14:15 Hrs [IST] Glenmark Pharmaceuticals Ltd, a research ...

The Nifty Pharma index closed on a positive note on Wednesday. Shares of Glenmark Pharmaceuticals Ltd.(up 2.03 per cent), ...

The NIFTY MIDCAP 150 reflects the performance of mid-sized companies, and these gains indicate positive momentum for the mentioned stocks within this index.